RHONE MA HOLDINGS BERHAD

KLSE: 5278 (RHONEMA)

Last update: 5 hours ago

0.605

-0.03 (-3.97%)

Previous Close 0.630
Open 0.610
Volume 11,000
Avg. Volume (3M) 34,505
Market Cap 133,841,736
Price / Earnings (TTM) 15.13
Price / Sales 0.860
Price / Book 0.800
52 Weeks Range
0.580 (-4%) — 0.800 (32%)
TTM Dividend Yield 4.13%
Profit Margin 5.82%
Operating Margin (TTM) 10.40%
Diluted EPS (TTM) 0.040
Quarterly Revenue Growth (YOY) -5.30%
Quarterly Earnings Growth (YOY) -5.50%
Total Debt/Equity (MRQ) 13.32%
Current Ratio (MRQ) 5.40
Operating Cash Flow (TTM) 18.41 M
Levered Free Cash Flow (TTM) 14.36 M
Return on Assets (TTM) 5.60%
Return on Equity (TTM) 7.43%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (MY) Mixed Mixed
Drug Manufacturers - Specialty & Generic (Global) Bearish Mixed
Stock RHONEMA Mixed Mixed

AIStockmoo Score

2.0
Analyst Consensus NA
Insider Activity NA
Price Volatility 4.0
Technical Moving Averages 2.5
Technical Oscillators -0.5
Average 2.00

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
RHONEMA 134 M 4.13% 15.13 0.800
KOTRA 593 M 6.38% 14.81 2.27
YSPSAH 305 M 5.12% 11.32 0.740
PLABS 83 M - 30.00 1.04
DPHARMA 1 B 2.48% 17.29 1.60

Rhone Ma Holdings Bhd is an investment holding company and are engaged in the provision of management services. It operates through its subsidiaries so it offers animal health services as well as the manufacturing and distribution of animal health products. The operating segments of the group are Animal health products and equipment , Food ingredients, and Others. Animal health products and equipment segment includes marketing, trading, distribution and manufacturing of animal health products and undertaking research and development activities related to animal health, food safety and agriculture in animal health products. The animal health products offered include vaccines, pharmaceuticals, and feed additives. It is also involved in the distribution and supply of food ingredients.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Value
% Held by Insiders 86.01%
% Held by Institutions 1.36%

No data within this time range.

Date Type Details
24 Apr 2025 Announcement Statement to Shareholders in relation to the Proposed Share Buy-Back Authority of up to 10% of the total number of issued shares of the Company
24 Apr 2025 Announcement Annual Report & CG Report - 2024
23 Apr 2025 Announcement General Meetings: Notice of Meeting
16 Apr 2025 Announcement RHONEMA - Notice of Book Closure
15 Apr 2025 Announcement Rhone Ma Holdings Berhad ("RMH" or 'the Company") - Proposed Share Buy-Back Authority
15 Apr 2025 Announcement Final Dividend
11 Apr 2025 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Intention to Deal During Closed Period
07 Apr 2025 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
07 Apr 2025 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
07 Apr 2025 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
03 Apr 2025 TheEdge Cover Story: Fatter dividends declared in FY2024 ahead of 2% dividend tax
13 Mar 2025 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
13 Mar 2025 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
13 Mar 2025 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - TEO KWEE HOCK
13 Mar 2025 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
12 Mar 2025 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
12 Mar 2025 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
12 Mar 2025 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
11 Mar 2025 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
11 Mar 2025 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
11 Mar 2025 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
07 Mar 2025 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
07 Mar 2025 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
07 Mar 2025 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
05 Mar 2025 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
05 Mar 2025 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
05 Mar 2025 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
04 Mar 2025 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR FOONG KAM WENG
04 Mar 2025 Announcement Changes in Director's Interest (Section 219 of CA 2016) - MR FOONG KAM WENG
04 Mar 2025 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
03 Mar 2025 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
03 Mar 2025 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
03 Mar 2025 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
21 Feb 2025 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
21 Feb 2025 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
21 Feb 2025 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
20 Feb 2025 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
20 Feb 2025 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
20 Feb 2025 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
19 Feb 2025 Announcement DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings During Closed Period
19 Feb 2025 Announcement Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG
19 Feb 2025 Announcement Press Release: Rhone Ma Holdings Berhad Delivers Strong FYE2024 Performance, Recording RM211.6 Million in Revenue
19 Feb 2025 Announcement Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG
19 Feb 2025 Announcement Quarterly rpt on consolidated results for the financial period ended 31/12/2024
19 Feb 2025 Announcement Rhone Ma Holdings Berhad ("RMH" or "Company") - Extension of Time for the Utilisation of Proceeds raised from the Private Placement.
Show more
TTM Dividend Yield 4.13%
5Y Average Dividend Yield 2.72%
Payout Ratio 61.27%
Expected Next Dividend Payment Nov 2025
Ex Date Announcement Date Payment Date Details
25 Jun 2025 15 Apr 2025 14 Jul 2025 0.01 Cash
13 Dec 2024 18 Nov 2024 27 Dec 2024 0.01 Cash
22 Oct 2024 08 Oct 2024 04 Nov 2024 0.005 Cash
27 Jun 2024 16 Apr 2024 15 Jul 2024 0.01 Cash
05 Jan 2024 15 Dec 2023 02 Feb 2024 0.01 Cash
28 Jun 2023 11 Apr 2023 17 Jul 2023 0.01 Cash
30 Dec 2022 15 Dec 2022 16 Jan 2023 0.01 Cash
01 Jul 2022 12 Apr 2022 15 Jul 2022 0.01 Cash
12 Jan 2022 24 Dec 2021 25 Jan 2022 0.01 Cash
01 Jul 2021 04 Jun 2021 15 Jul 2021 0.01 Cash
02 Jul 2020 06 May 2020 15 Jul 2020 0.01 Cash
02 Jul 2019 29 Apr 2019 15 Jul 2019 0.02 Cash
29 Jan 2019 15 Jan 2019 13 Feb 2019 0.01 Cash
Show more

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2025 0.010 1 1.65
2024 0.035 4 5.19
2023 0.020 2 2.90
2022 0.020 2 2.94
2021 0.010 1 1.35
2020 0.010 1 1.24
2019 0.030 2 4.51
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria